Medicare Enrolled
Dr. Gerard Curtis, M.D.
Urology Physician · Sarasota, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Curtis from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Curtis?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Curtis
Dr. Gerard Curtis is an urology physician in Sarasota, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Curtis performed 4,487 Medicare services across 3,155 unique beneficiaries.
Between the years covered by Open Payments, Dr. Curtis received a total of $6,011 from 47 pharmaceutical and/or device companies across 251 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Curtis is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 27% volume in FL
$6,011 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 69572 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗4,487
Medicare services
Top 27% in FL for urology physician
3,155
Unique beneficiaries
$79
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~224 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,593 | $88 | $254 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
306 | $0 | $1 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
294 | $2 | $5 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
269 | $75 | $225 |
| Limited ultrasound of pelvis A focused ultrasound exam of the pelvic area to evaluate specific structures. This procedure provides images of the pelvis to assist in medical assessment. |
226 | $35 | $96 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
200 | $165 | $475 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
156 | $65 | $180 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
132 | $90 | $164 |
| Additional urethral implant in prostate Placement of an additional implant into the urethra within the prostate gland using an endoscope. |
118 | $40 | $103 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
107 | $11 | $28 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 96 | $136 | $384 |
| Limited retroperitoneal ultrasound A focused ultrasound exam of the area behind the abdominal cavity to evaluate specific structures. |
94 | $43 | $117 |
| Home health plan of care certification Certification by a physician or allowed practitioner for Medicare-covered home health services under a home health plan of care. This includes contacting the home health agency and reviewing reports of patient status required by physicians. |
90 | $40 | $103 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
78 | $233 | $653 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
73 | $8 | $21 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
62 | $124 | $334 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
60 | $19 | $49 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
42 | $247 | $638 |
| Insertion of temporary bladder tube | 40 | $34 | $89 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
39 | $104 | $390 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
38 | $65 | $186 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
35 | $182 | $481 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
33 | $325 | $865 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
31 | $26 | $66 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
29 | $126 | $358 |
| Urethral implant insertion in prostate A single implant is placed into the urethra within the prostate gland using an endoscope. |
27 | $158 | $424 |
| Hormone pellet insertion under the skin A small hormone pellet is placed just beneath the skin to release medication slowly over time. |
22 | $74 | $189 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
21 | $41 | $122 |
| Endoscopic destruction of bladder/urethra growth, less than 0.5 cm A procedure to remove abnormal tissue growths from the bladder or urethra using an endoscope. This specific code applies when the growths are smaller than 0.5 centimeters. |
20 | $600 | $1,538 |
| Other procedure on male genital system A surgical or medical intervention performed on the male genital organs that does not fall under other specific categories. |
20 | $133 | $854 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
20 | $94 | $266 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
19 | $6 | $28 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
19 | $25 | $128 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
18 | $86 | $364 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
18 | $24 | $61 |
| Aspiration of fluid collection in testicle and sperm reservoir A procedure to remove fluid from a collection in the testicle or sperm reservoir using a needle. |
17 | $93 | $242 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
13 | $564 | $1,479 |
| Endoscopic removal of bladder or urethra growth, 2.0-5.0 cm This procedure uses an endoscope to destroy or remove a growth from the bladder or urethra that measures between 2.0 and 5.0 centimeters. |
12 | $228 | $582 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.1% high complexity
22.0% medium
75.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,011
Total received (2018-2024)
Avg $859/year across 7 years
Top 35% in FL for urology physician
47
Companies
251
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,912 (98.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$99 (1.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,074
2023
$770
2022
$636
2021
$929
2020
$450
2019
$1,012
2018
$1,141
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Antares Pharma, Inc.
$655
Endo Pharmaceuticals Inc.
$651
Janssen Biotech, Inc.
$440
Teleflex LLC
$401
Astellas Pharma US Inc
$347
PFIZER INC.
$237
AMAG Pharmaceuticals, Inc.
$194
PROCEPT BioRobotics Corporation
$186
Olympus America Inc.
$181
Sumitomo Pharma America, Inc.
$174
TherapeuticsMD, Inc.
$157
Boston Scientific Corporation
$144
Medtronic, Inc.
$139
Medtronic USA, Inc.
$138
Retrophin, Inc.
$128
Tolmar, Inc.
$125
Coloplast Corp
$119
Axonics, Inc.
$108
TOLMAR Pharmaceuticals, Inc.
$104
Valencia Technologies Corporation
$103
Janssen Products, LP
$99
Aytu BioScience, Inc
$97
COLOPLAST CORP
$92
ABBVIE INC.
$91
Allergan, Inc.
$82
Supernus Pharmaceuticals, Inc.
$80
Allergan Inc.
$72
BOSTON SCIENTIFIC CORPORATION
$66
Acerus Pharmaceuticals Corporation
$64
AbbVie Inc.
$58
Wilmington Medical Supply, Inc.
$54
Clarus Therapeutics Inc.
$51
UROVANT SCIENCES INC
$47
C. R. Bard, Inc. & Subsidiaries
$44
Novartis Pharmaceuticals Corporation
$43
Egalet US Inc
$33
Blue Earth Diagnostics Limited
$32
AbbVie, Inc.
$29
Endo USA, Inc.
$24
Bayer HealthCare Pharmaceuticals Inc.
$18
Ferring Pharmaceuticals Inc.
$18
Amgen Inc.
$18
C. R. BARD, INC. & SUBSIDIARIES
$16
Rochester Medical Corporation
$15
ROCHESTER MEDICAL CORPORATION
$14
NeoTract Inc.
$12
Photocure Inc
$11
Top 3 companies account for 29.0% of total payments
Associated products mentioned in payments ›
(815) Thiola · AFINITOR · ALTIS · AMS · AQUABEAM SYSTEM · AVEED · Altis · Androgel · Axonics · Axumin · BOTOX · Cysview · EDEX · ELIGARD · ERLEADA · Erleada · FLEXIVA · GEMTESA · IMVEXXY · INTERSTIM · INTERSTIM ICON · INTRAROSA · JATENZO · Luja Coude · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · OTREXUP · Otrexup · PLUVICTO · Prolia · REZUM · SPRIX · SpeediCath · TLANDO · TOVIAZ · Titan · UGN Laser Capital · UROLIFT · UroLift · UroLift System · Verquvo · Virtue · XIAFLEX · XTANDI · XYOSTED · ZYTIGA · eCoin Device Kit · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $134 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
38
Per 100K population
8.5
County median income
$80,633
Nearest hospital
HCA FLORIDA SARASOTA DOCTORS HOSPITAL
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Curtis is a clinical cardiology specialist, with above-average Medicare volume (top 27% in FL), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Curtis experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Curtis performed 1,593 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Curtis receive payments from pharmaceutical companies?
Yes. Dr. Curtis received a total of $6,011 from 47 companies across 251 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Curtis's costs compare to other urology physicians in Sarasota?
Dr. Curtis's average Medicare payment per service is $79. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Curtis) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Sarasota
Browse urology physicians in Sarasota ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in FL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in FL
Which FL urology physicians receive the most from drug and device companies.
By company
Antares Pharma, Inc. Payments to Doctors
See all physicians who received payments from Antares Pharma, Inc.
By company
Endo Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Endo Pharmaceuticals Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology